Lycopene and chemotherapy toxicity

Nutrition and Cancer

Volumn 62, Issue 7, 2010, Pages 988-995

  Sahin, Kazim ^a   Sahin, Nurhan ^a   Kucuk, Omer ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTHRACYCLINE; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; BLEOMYCIN; BUTYRIC ACID; CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LYCOPENE; MELPHALAN; PACLITAXEL; PLATINUM DERIVATIVE; PODOPHYLLIN; REACTIVE OXYGEN METABOLITE; RETINOL; TOPOTECAN; VINBLASTINE; VINCRISTINE; XANTHOPHYLL; ZEAXANTHIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CYSTITIS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG POTENTIATION; HEART PROTECTION; HUMAN; LIVER TOXICITY; LUNG ALVEOLITIS; LUNG FIBROSIS; MUCOSA INFLAMMATION; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; RENAL PROTECTION; REVIEW; SINGLE DRUG DOSE; SKIN TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

LYCOPERSICON ESCULENTUM;

EID: 77958001869     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.509838     Document Type: Review

References (62)

1. Conklin KA: Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37, 1-18, 2000.
2. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, et al.: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100, 773-783, 2008.
3. Yilmaz S, Sahna E, Karahan I, and Ozer S: Protective effect of lycopene on Adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218, 164-171, 2006.
4. Dogukan A, Tuzcu M, Agca CA, Gencoglu H, Sahin N, et al.: A Tomato lycopene complex protects the kidney from cisplatin-induced injury by affecting oxidative stress, Bax, Bcl-2 and HSPs expression. Nutr Cancer 2010. Forthcoming.
5. Do Amaral CL, Francescato HD, Coimbra TM, Costa RS, Darin JD, et al.: Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch Toxicol 82, 363-370, 2008.
6. Tatlidede E, Sehirli O, Velioglu-Ogunc A, Cetinel S, Yegen BC, et al.: Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radic Res 43, 195-205, 2009.
7. Berthiaume JM, Oliveira PJ, Fariss MW, and Wallace KB: Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol 5, 257-267, 2005.
8. Deres P, Halmosi R, Toth A, Kovacs K, Palfi A, et al.: Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J Cardiovasc Pharmacol 45, 36-43, 2005.
9. Maliakel DM, Kagiya TV, and Nair CK: Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Exp Toxicol Pathol 60, 521-527, 2008.
10. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, et al.: Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 28, 1635-1638, 2005.
11. Kuhad A, Pilkhwal S, Sharma S, Tirkey N, and Chopra K: Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 55, 10150-10155, 2007.
12. Mohamad RH, El-Bastawesy AM, Zekry ZK, Al-Mehdar HA, Al-Said MG, et al.: The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food 12, 394-402, 2009.
13. Razo-Rodríguez AC, Chirino YI, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, et al.: Garlic powder ameliorates cisplatin-induced nephrotoxicity and oxidative stress. J Med Food 11, 582-586, 2008.
14. Psotová J, Chlopcíková S, Miketová P, Hrbác J, and Simánek V: Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes: Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin. Phytother Res 18, 516-521, 2004. (Pubitemid 39079145)
15. Sies H: Oxidative stress: oxidants and antioxidants. Exp Physiol 82, 291-295, 1997.
16. Beckman KB and Ames BN: The free radical theory of aging matures. Physiol Rev 78, 547-581, 1998.
17. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, et al.: Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 33, 407-418, 2007.
18. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, et al.: Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 123, 1227-1239, 2008.
19. Chen Y, Jungsuwadee P, Vore M, Butterfield DA, and St Clair DK: Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv 7, 147-156, 2007.
20. Hug H, Strand S, Grambihler A, Galle J, Hack V, et al.: Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Bio Chem 272, 28191-28193, 1997.
21. Singal PK, Iliskovic N, Li T, and Kumar D: Adriamycin cardiomyopathy: Pathophysiology and prevention. FASEB J 11, 931-936, 1997.
22. Tangpong J, Cole MP, Sultana R, Estus S, Vore M, et al.: Adriamycinmediated nitration of manganese superoxide dismutase in the central nervous system: Insight into the mechanism of chemobrain. J Neurochem 100, 191-201, 2007.
23. Alberts DS and Noel JK: Cisplatin-associated neurotoxicity: can it be prevented? Anticancer Drug 6, 369-383, 1995.
24. Taguchi T, Nazneen A, Abid MR, and Razzaque MS: Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148, 107-121, 2005.
25. Hrelia S, Bordoni A, Angeloni C, Leoncini E, and Biagi P: Nutritional interventions to counteract oxidative stress in cardiac cells. Ital J Biochem 53, 157-163, 2004.
26. Clemens MR, Waladkhani AR, Bublitz K, Ehninger G, and Gey KF: Supplementation with antioxidants prior to bone marrow transplantation. Wien Klin Wochenschr 109, 771-776, 1997.
27. Agarwal S and Rao AV: Tomato lycopene and its role in human health and chronic diseases. CMAJ 163, 739-744, 2000.
28. Nguyen ML and Schwartz SJ: Lycopene: chemical and biological properties. Food Technol 53, 38-45, 1999.
29. DiMascio P, Kaiser S, and Sies H: Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532-538, 1989.
30. Heber D and Lu Q-Y: Overview of mechanisms of action of lycopene. Exp Biol Med 227, 920-923, 2002.
31. Amin AR, Kucuk O, Khuri FR, and Shin DM: Perspectives for cancer prevention with natural compounds. J Clin Oncol 27, 2712-2725, 2009.
32. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, et al.: Phase II randomized clinical trial oflycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10, 861-868, 2001.
33. Seren S, Lieberman R, Bayraktar UD, Heath E, Sahin K, et al.: Lycopene in cancer prevention and treatment. Am J Ther 15, 66-81, 2008.
34. Bertram JS: Carotenoids and gene regulation. Nutrition Rev 57, 182-191, 1999.
35. Karas M, Amir H, Fishman D, Danilenko M, Segal S, et al.: Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36, 101-111, 2000.
36. Giovannucci E: A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med 227, 852-859, 2002.
37. Bertram JS and Bortkiewicz H: Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 62, 1327-1336, 1995.
38. Zhang L-X, Cooney RV, and Bertram JS: Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12, 2109-2114, 1991.
39. Gius D, Botero A, Shah S, and Curry HA: Intracellular oxidation/reduction status in the regulation of transcription factors NFkappaB and AP-1. Toxicol Lett 106, 93-106, 1999.
40. Rao AV, Fleshner N, and Agarwal S: Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr Cancer 33, 159-164, 1999.
41. Siler U, Barella L, Spitzer V, Scnorr J, Lein M, et al.: Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 18, 1019-1021, 2004.
42. Hazai E, Bikadi Z, Zsila S, and Lockwood SF: Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyl, and selected oxidative metabolites with 5-lipoxygenase. Bioorg Med Chem 14, 6859-6867, 2006.
43. Jewell C and O'Brien NM: Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br J Nutr 81, 235-242, 1999.
44. Chew BP and Park JS: Carotenoid action on the immune response. J Nutr 134, 257-261, 2004.
45. Faber M, Coudray C, Hida H, Mousseau M, and Favier A: Lipid peroxidation products and vitamin and trace element status in patients with cancer before and after chemotherapy including adriamycin. a preliminary study. Biol Trace Elem Res 47, 117-123, 1995.
46. Sangeetha P, Das UN, Koratkar R, and Suryaprabha P: Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 8, 15-19, 1990.
47. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EGWM, Berger HM, et al.: Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 9, 1331-1337, 1998.
48. Erhola M, Kellokumpu-Lehtinen P, Metsa-Ketela T, Alanko K, and Nieminen MM: Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radic Biol Med 21, 383-390, 1996.
49. D'Incalci M, Steward WP, and Gescher AJ: Modulation of response to cancer chemotherapeutic agents by diet constituents: is the available evidence sufficiently robust for rational advice for patients? Cancer Treat Rev 33, 223-229, 2007.
50. Salganik RI: The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20, 464-472, 73-75, 2001.
51. Prasad KN, Kumar A, Kochupillai V, and Cole WC: High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18, 13-25, 1999.
52. Karimi G, Ramezani M, and Abdi A: Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytother Res 19, 912-914, 2005.
53. Sendão MC, Behling EB, dos Santos RA, Antunes LM, and de Lourdes Pires Bianchi M: Comparative effects of acute and subacute lycopene administration on chromosomal aberrations induced by cisplatin in male rats. Food Chem Toxicol 44, 1334-1339, 2006.
54. Zhou C, Han W, Zhang P, Cai M, Wei D, et al.: Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res 28, 122-130, 2008.
55. Ferreira AL, Salvadori DM, Nascimento MC, Rocha NS, Correa CR, et al.: Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats. Mutat Res 631, 26-35, 2007.
56. Rios AO, Antunes LMG, and Bianchi MLP: Bixin and lycopene modulation of free radical generation induced by cisplatin-DNA interaction. Food Chemistry 113, 1113-1118, 2009.
57. Van Breemen RB and Pajkovic N: Multitargeted therapy of cancer by lycopene. Cancer Lett 269, 339-351, 2008.
58. Krinsky NI: Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 200, 248-254, 1992.
59. Bast A, Haenen GR, Van Den Berg R, and Van Den Berg H: Antioxidant effects of carotenoids. Int J Vitam Nutr Res 68, 399-403, 1998.
60. Park YO, Hwang ES, and Moon TW: The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors 23, 129-139, 2005.
61. Avci A, Cetin R, Erguder IB, Devrim E, Kilicoglu B, et al.: Cisplatin causes oxidation in rat liver tissues: possible protective effects of antioxidant food supplementation. Turk J Med Sci 38, 117-120, 2008.
62. Puri T, Julka PK, Goyal S, Nair O, Sharma DN, et al.: Role of natural lycopene and phytonutrients along with radiotherapy and chemotherapy in high-grade gliomas. J Clin Oncol 2005 ASCO Annual Meeting Proc 23 (16 Suppl), 1561, 2005.